Although Ozempic, Mounjaro, and Rybelsus are not FDA-approved for obesity treatment, they are included in the analysis due to the high number of patients with an obesity diagnosis using these products compared to other FDA-approved Type 2 diabetes GLP-1 agonists
In clinical comparisons, single-receptor GLP-1 agonists (Semaglutide) and dual-receptor GIP/GLP-1 agonists (Mounjaro / Tirzepatide) represented significant advances in metabolic science
We used a slice thickness of 0.5 mm and 29 slices with a scan time of 15 min to image the whole brain
This latest addition will give members a new once-daily GLP-1 option for adults living with type 2 diabetes, further expanding Weight Watchers growing portfolio of oral GLP-1 treatments available through a clinically supported program designed to help members succeed
For example, ongoing research aims to identify new analogs or formulations of GLP-1 that may offer improved dosing regimens, reduced side effects, or enhanced efficacy
Of course, our other recommendations also let you titrate as needed, but to potentially less effect
